Skip to content

cobas b 221 <4> system 3337138001Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Adverse event reports
7
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 04015630018321), received between Oct 1, 2018 and Jul 14, 2025 — classified as 7 malfunctions.

The most frequently reported specific device problem is “Low Test Results” (3 reports).

1 FDA recall record name this device's identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 3 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520263
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Feb 22, 2018Terminated

    The software responsible for starting scheduled AutoQC measurements (scheduler) will not activate.

    Z-1611-2018 · Root cause: Software design · FDA record ↗

Most reported problems

Device problems

  • Low Test Results3
  • Incorrect, Inadequate or Imprecise Result or Readings2
  • High Test Results1
  • Non Reproducible Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions6
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 14, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 1 PATIENT SAMPLE TESTED WITH THE IONIZED CALCIUM ASSAY ON A COBAS B 221 <4> SYSTEM. THE INITIAL RESULT WAS 1.52 MMOL/L. THE REPEAT RESULTS WERE 1.14 MMOL/L WHEN TESTED ON ANOTHER GASOMETER AND A COBAS C311 ANALYZER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22495219 ↗
  • MalfunctionNov 4, 2024Low Test Results; Low Test Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE GEN.2 ISE INDIRECT FOR K, NA, AND CL RESULTS FOR 1 PATIENT SAMPLE ON A COBAS B 221 BLOOD GAS ANALYZER. THIS MEDWATCH WILL COVER CL. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE K RESULTS AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE NA RESULTS. THE CUSTOMER QUESTIONED THE B 221 RESULTS AS THEY DID NOT MATCH THE PATIENT'S SERUM RESULTS FROM A C503 ANALYZER. THE PATIENT SAMPLES USED FOR THE ANALYZERS WERE REPORTEDLY COLLECTED AND PROCESSED AT THE SAME TIME. THE WHOLE BLOOD ARTERIAL SAMPLE ON THE B221 ANALYZER HAD A K RESULT OF 2.81 MMOL/L, A NA RESULT OF 129.7 MMOL/L, AND A CL RESULT OF 86.8 MMOL/L. A SERUM SAMPLE FROM THE PATIENT WAS TESTED ON A C503 ANALYZER AND THE K RESULT WAS 4.1 MMOL/L, A NA RESULT OF 137.5 MMOL/L, AND A CL RESULT OF 99.0 MMOL/L. THE REPEATED RESULTS WERE DEEMED CORRECT AS THE RESULTS CORRELATED WITH THE PATIENT'S CLINICAL PICTURE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20599165 ↗
  • MalfunctionNov 4, 2024Low Test Results; Low Test Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE GEN.2 ISE INDIRECT FOR K, NA, AND CL RESULTS FOR 1 PATIENT SAMPLE ON A COBAS B 221 BLOOD GAS ANALYZER. THIS MEDWATCH WILL COVER K. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE CL RESULTS AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE NA RESULTS. THE CUSTOMER QUESTIONED THE B 221 RESULTS AS THEY DID NOT MATCH THE PATIENT'S SERUM RESULTS FROM A C503 ANALYZER. THE PATIENT SAMPLES USED FOR THE ANALYZERS WERE REPORTEDLY COLLECTED AND PROCESSED AT THE SAME TIME. THE WHOLE BLOOD ARTERIAL SAMPLE ON THE B221 ANALYZER HAD A K RESULT OF 2.81 MMOL/L, A NA RESULT OF 129.7 MMOL/L, AND A CL RESULT OF 86.8 MMOL/L. A SERUM SAMPLE FROM THE PATIENT WAS TESTED ON A C503 ANALYZER AND THE K RESULT WAS 4.1 MMOL/L, A NA RESULT OF 137.5 MMOL/L, AND A CL RESULT OF 99.0 MMOL/L. THE REPEATED RESULTS WERE DEEMED CORRECT AS THE RESULTS CORRELATED WITH THE PATIENT'S CLINICAL PICTURE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20599143 ↗
  • MalfunctionNov 4, 2024Low Test Results; Low Test Results

    THERE WAS AN ALLEGATION OF QUESTIONABLE GEN.2 ISE INDIRECT FOR K, NA, AND CL RESULTS FOR 1 PATIENT SAMPLE ON A COBAS B 221 BLOOD GAS ANALYZER. THIS MEDWATCH WILL COVER NA. REFER TO MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE CL RESULTS AND MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR INFORMATION ON THE K RESULTS. THE CUSTOMER QUESTIONED THE B 221 RESULTS AS THEY DID NOT MATCH THE PATIENT'S SERUM RESULTS FROM A C503 ANALYZER. THE PATIENT SAMPLES WERE REPORTEDLY COLLECTED AND PROCESSED AT THE SAME TIME. THE WHOLE BLOOD ARTERIAL SAMPLE ON THE B221 ANALYZER HAD A K RESULT OF 2.81 MMOL/L, A NA RESULT OF 129.7 MMOL/L, AND A CL RESULT OF 86.8 MMOL/L. A SERUM SAMPLE FROM THE PATIENT WAS TESTED ON A C503 ANALYZER AND THE K RESULT WAS 4.1 MMOL/L, A NA RESULT OF 137.5 MMOL/L, AND A CL RESULT OF 99.0 MMOL/L. THE REPEATED RESULTS WERE DEEMED CORRECT AS THE RESULTS CORRELATED WITH THE PATIENT'S CLINICAL PICTURE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20599113 ↗
  • MalfunctionFeb 28, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

    THE INITIAL REPORTER STATED THEY RECEIVED QUESTIONABLE RESULTS FOR ONE PATIENT SAMPLE TESTED ON A COBAS B 221 4 SYSTEM. RESULTS FOR THE FOLLOWING PARAMETERS WERE QUESTIONABLE: PCO2, PO2, PH, NA+, K+, CA2+, SO2, BE, P50. A FIRST SAMPLE WAS COLLECTED FROM THE PATIENT WAS TESTED ON THE ANALYZER AT 18:30, RESULTING IN THE FOLLOWING VALUES: PCO2 = 53.5 MMHG WITH A DATA FLAG PO2 = 74.0 MMHG WITH A DATA FLAG PH = 7.089 WITH A DATA FLAG NA+ = 131.5 MMOL/L WITH A DATA FLAG K+ = "OUT OF RANGE" (> 20.00 MMOL/L) WITH A DATA FLAG CA2+ = "OUT OF RANGE" (< 0.100 MMOL/L) WITH A DATA FLAG SO2 = 86.8 % WITH A DATA FLAG BE = -13.8 MMOL/L P50 = 37.6 MMHG THE RESULTS FROM THE FIRST SAMPLE SHOWED SEVERE RESPIRATORY ACIDOSIS BASED ON THE PH, PCO2, AND BE RESULTS. AS THE RESULTS DID NOT CORRELATE TO THE CLINICAL CONDITION OF THE PATIENT, A SECOND SAMPLE WAS COLLECTED FROM THE PATIENT AND TESTED ON THE ANALYZER. THE SECOND SAMPLE WAS TESTED AT 18:49 AND RESULTED IN THE FOLLOWING VALUES: PCO2 = 31.8 MMHG WITH A DATA FLAG PO2 = 44.3 MMHG WITH A DATA FLAG PH = 7.396 NA+ = 146.1 MMOL/L WITH A DATA FLAG K+ = 2.92 MMOL/L WITH A DATA FLAG CA2+ = 0.557 MMOL/L WITH A DATA FLAG SO2 = 75.9 % WITH A DATA FLAG BE = -5.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18798005 ↗
  • MalfunctionMar 1, 2023High Test Results; High Test Results

    THE INITIAL REPORTER QUESTIONED HIGH POTASSIUM (K) RESULTS FOR 5 PATIENTS TESTED ON TWO COBAS B 221 SYSTEMS. THE CUSTOMER IS QUESTIONING THE RESULTS FROM WHOLE BLOOD SAMPLES RUN ON THE B 221 INSTRUMENTS COMPARED TO RESULTS FROM PLASMA SAMPLES RUN ON NON-ROCHE INSTRUMENTS IN THE HOSPITAL LABORATORY. ARTERIAL BLOOD SAMPLES WERE OBTAINED FROM THE ARTERIAL LINE FOR RUNNING ON THE B 221 INSTRUMENTS. DUE TO THE HIGH K RESULTS, PLASMA SAMPLES WERE DRAWN AND SENT TO THE LABORATORY WHERE THE RESULTS WERE "NORMAL." REFER TO THE ATTACHED DATA FOR THE PATIENT RESULTS. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE CUSTOMER USED THE RESULTS FROM THE LABORATORY TO MONITOR THE PATIENT¿S CONDITION. THE K ELECTRODE LOT NUMBER WAS 21523447. THE EXPIRATION DATE WAS NOT PROVIDED. THE ELECTRODE WAS INSTALLED IN AUG-2022.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16463803 ↗
  • MalfunctionOct 1, 2018Non Reproducible Results; Non Reproducible Results

    THE CUSTOMER RECEIVED A QUESTIONABLE TOTAL HEMOGLOBIN (THB) RESULT FOR ONE PATIENT WITH A COBAS B 221 ANALYZER WHEN COMPARED TO A MEDICA INSTRUMENT. OF THE DATA PROVIDED, THERE WERE DISCREPANT RESULTS FOR THE THB AND PARTIAL PRESSURE OF OXYGEN (PO2) TESTS. THE THB RESULT FROM THE B 221 WAS 8.4 G/DL AND THE REPEAT RESULT FROM THE MEDICA INSTRUMENT WAS 11.7 G/DL. THE SAMPLE WAS REPEATED TWO MORE TIMES ON THE B 221 AND THE RESULTS WERE 13.5 G/DL AND 11.4 G/DL. THE PO2 RESULT FROM THE B 221 WAS 133.0 MMHG AND THE REPEAT RESULT FROM THE MEDICA INSTRUMENT WAS 133 MMHG. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. NO ERRONEOUS RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE CALIBRATION AND QC WERE ACCEPTABLE. THE SENSOR CARTRIDGE S1 LOT NUMBER WAS 21481005 WITH AN EXPIRATION DATE OF 02-MAR-2018 AND S2 LOT NUMBER WAS 21482019 WITH AN EXPIRATION DATE OF 11-NOV-2018.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7922864 ↗

Other ELECTRODE, ION SPECIFIC, POTASSIUM devices

All ELECTRODE, ION SPECIFIC, POTASSIUM devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.